[Sinonasal hemangiopericytomas]

[Sinonasal Hemangiopericytoma: diagnostic and therapeutic challenge]

L'hemangiopericytome est une tumeur vasculaire rare, développée à partir des pericytes des capillaires, dans sa localisation nasosinusienne elle ne représente que 0 .5% de l'ensemble des tumeurs de cette région. Une jeune de 35ans a présenté une tumeur rapidement évolutive au cours du bilan diagnostic, l’étude anatomopathologique a conclu à un hémangiopericytome.

Systematic review of treatment and prognosis of sinonasal hemangiopericytoma

BACKGROUND

This study was undertaken to determine the recurrence rate for open and endoscopic surgery and the clinical prognosis of this sinonasal tumor.

METHODS

A systematic review of individual cases of sinonasal hemangiopericytoma was performed. A total of 97 articles were included in the study and reviewed to extract the relevant information about each case.

RESULTS

In all, 194 cases of sinonasal hemangiopericytoma were identified. There were 53 recurrences (27.3%), 6 tumor-related deaths (3.1%), and 4 cases of metastases (2.1%). There was no significant difference between rate of recurrence for endoscopic or open resection (p = .06). Incomplete excision was the most important predictor of recurrence (odds ratio = 11.50, 95% confidence interval 3.76-36.82, p < .001). Radiotherapy may be advantageous in cases of incomplete surgical resection (p = .03).

CONCLUSIONS

Complete excision is essential to minimize tumor recurrence and radiotherapy may decrease the rate of recurrence in the case of incomplete resection. Current evidence does not suggest that open resection is superior to endoscopic resection.